Phase 2 Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women aged 18 to 75 years old
- People with a confirmed breast cancer type known as HR-positive, HER2-negative (meaning the cancer tests positive for hormone receptors but negative for a protein called HER2, based on specific lab measurements)
- People whose cancer has been identified as a specific breast cancer subtype called "SNF-3," confirmed by a specialist pathology lab at Fudan University Cancer Hospital
- People whose cancer is either locally advanced (not able to be fully treated with local treatments) or has spread to other parts of the body
- People whose cancer can be measured on scans, or who have certain types of bone involvement that may not be measurable in the usual way
- People whose bone marrow is working well enough, shown by blood test results meeting minimum levels for white blood cells, platelets, and haemoglobin
- People who have not previously had chemotherapy or targeted therapy for their advanced or spread cancer
- People whose liver and kidney function tests meet the required levels (confirm with trial site for specific values)
- People with a general health performance score of 2 or less on a standard medical scale, and a life expectancy of at least 3 months
- People who are willing to participate, have signed a consent form, and have agreed to attend follow-up appointments
Who may not be able to join:
- People who have already received chemotherapy, radiotherapy, immunotherapy, or major surgery to treat their advanced or spread cancer
- People who have brain or spinal cord cancer spread that is causing symptoms, has not been treated, or is getting worse, particularly if medication is needed to manage symptoms
- People who have had significant heart problems in the past 6 months, such as heart failure, chest pain from the heart, a heart attack, or serious irregular heartbeat
- People who are currently pregnant or breastfeeding
- People who have had another cancer diagnosis in the past five years (with the exception of certain fully treated skin cancers or early-stage cervical cell changes)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 86-021-64175590
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
PFS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.